Correlation Between RAMM Pharma and Avicanna
Can any of the company-specific risk be diversified away by investing in both RAMM Pharma and Avicanna at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining RAMM Pharma and Avicanna into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between RAMM Pharma Corp and Avicanna, you can compare the effects of market volatilities on RAMM Pharma and Avicanna and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in RAMM Pharma with a short position of Avicanna. Check out your portfolio center. Please also check ongoing floating volatility patterns of RAMM Pharma and Avicanna.
Diversification Opportunities for RAMM Pharma and Avicanna
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between RAMM and Avicanna is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding RAMM Pharma Corp and Avicanna in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Avicanna and RAMM Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on RAMM Pharma Corp are associated (or correlated) with Avicanna. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Avicanna has no effect on the direction of RAMM Pharma i.e., RAMM Pharma and Avicanna go up and down completely randomly.
Pair Corralation between RAMM Pharma and Avicanna
If you would invest 21.00 in Avicanna on August 31, 2024 and sell it today you would earn a total of 2.00 from holding Avicanna or generate 9.52% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Flat |
| Strength | Insignificant |
| Accuracy | 5.88% |
| Values | Daily Returns |
RAMM Pharma Corp vs. Avicanna
Performance |
| Timeline |
| RAMM Pharma Corp |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
| Avicanna |
RAMM Pharma and Avicanna Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with RAMM Pharma and Avicanna
The main advantage of trading using opposite RAMM Pharma and Avicanna positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if RAMM Pharma position performs unexpectedly, Avicanna can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Avicanna will offset losses from the drop in Avicanna's long position.| RAMM Pharma vs. City View Green | RAMM Pharma vs. Speakeasy Cannabis Club | RAMM Pharma vs. Pure Harvest Cannabis | RAMM Pharma vs. Ravenquest Biomed |
| Avicanna vs. Pharmacielo | Avicanna vs. Khiron Life Sciences | Avicanna vs. Flower One Holdings | Avicanna vs. Cansortium |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.
Other Complementary Tools
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Fundamental Analysis View fundamental data based on most recent published financial statements |